In contrast, a study conducted among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa investigated that patients with baseline CD4 counts <50 cells/μl had similar/higher rates of CD4 cell recovery and a lower risk of immunological non-response [9]. The gene discussed is CD4; the disease is Immunodeficiency.